Skip to main content
Top
Published in: Tumor Biology 3/2016

01-03-2016 | Original Article

Authentication of newly established human esophageal squamous cell carcinoma cell line (YM-1) using short tandem repeat (STR) profiling method

Authors: Khosravi Ayyoob, Khoshnia Masoud, Kazeminejad Vahideh, Asadi Jahanbakhsh

Published in: Tumor Biology | Issue 3/2016

Login to get access

Abstract

Cross-contamination during or early after establishment of a new cell line could result in the worldwide spread of a misidentified cell line. Therefore, newly established cell lines need to be authenticated by a reference standard method. This study was conducted to investigate the authenticity of a newly established epithelial cell line of human esophageal squamous cell carcinoma (ESCC) called YM-1 using short tandem repeat (STR) DNA profiling method. Primary human ESCC epithelial cells were cultured from the fresh tumor tissue of an adult female patient. Growth characteristics and epithelial originality of YM-1 cells were studied. Genomic DNA was isolated from YM-1 cells harvested at passage 22 and ESCC donor tumor sample on two different days to prevent probable DNA contamination. STR profiling was performed using AmpFℓSTR® Identifiler® Plus PCR Amplification Kit. To address whether YM-1 cells undergo genetic alteration as the passage number increases, STR profiling was performed again on harvested cells at passage 51. YM-1 cells grew as a monolayer with a population doubling time of 40.66 h. Epithelial originality of YM-1 cells was confirmed using ICC/IF staining of cytokeratins AE1/AE3. The STR profile of the ESCC donor tumor sample was the same with YM-1 cells at passage 22. However, STR profile of the donor tumor sample showed an off-ladder (OL) allele in their D7S820 locus. Also, re-profiling of YM-1 cells at passage 51 showed a loss of heterozygosity (LOH) at D18S51 locus. This suggests that long-term culture of cell lines may alter their DNA profile. Comparison of the DNA fingerprinting results in DSMZ, and ATCC STR profiling databases confirmed unique identity of YM-1 cell line. This study provides an easy, fast, and reliable procedure for authentication of newly established cell lines, which helps in preventing the spread of misidentified cells and improving the reproducibility and validity of experiments, consequently.
Literature
1.
go back to reference Boonstra JJ, van der Velden AW, Beerens EC, van Marion R, Morita-Fujimura Y, Matsui Y, et al. Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7. Cancer Res. 2007;67:7996–8001.CrossRefPubMed Boonstra JJ, van der Velden AW, Beerens EC, van Marion R, Morita-Fujimura Y, Matsui Y, et al. Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7. Cancer Res. 2007;67:7996–8001.CrossRefPubMed
2.
go back to reference Dirks WG, Faehnrich S, Estella IA, Drexler HG. Short tandem repeat DNA typing provides an international reference standard for authentication of human cell lines. ALTEX. 2005;22:103–9.PubMed Dirks WG, Faehnrich S, Estella IA, Drexler HG. Short tandem repeat DNA typing provides an international reference standard for authentication of human cell lines. ALTEX. 2005;22:103–9.PubMed
3.
go back to reference Hughes P, Marshall D, Reid Y, Parkes H, Gelber C: The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? Biotechniques 2007, 43:575, 577–578, 581–572 passim. Hughes P, Marshall D, Reid Y, Parkes H, Gelber C: The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? Biotechniques 2007, 43:575, 577–578, 581–572 passim.
4.
go back to reference van Staveren WC, Solis DY, Hebrant A, Detours V, Dumont JE, Maenhaut C. Human cancer cell lines: experimental models for cancer cells in situ? For cancer stem cells? Biochim Biophys Acta. 1795;2009:92–103. van Staveren WC, Solis DY, Hebrant A, Detours V, Dumont JE, Maenhaut C. Human cancer cell lines: experimental models for cancer cells in situ? For cancer stem cells? Biochim Biophys Acta. 1795;2009:92–103.
5.
go back to reference Geraghty RJ, Capes-Davis A, Davis JM, Downward J, Freshney RI, Knezevic I, et al. Guidelines for the use of cell lines in biomedical research. Br J Cancer. 2014;111:1021–46.CrossRefPubMedPubMedCentral Geraghty RJ, Capes-Davis A, Davis JM, Downward J, Freshney RI, Knezevic I, et al. Guidelines for the use of cell lines in biomedical research. Br J Cancer. 2014;111:1021–46.CrossRefPubMedPubMedCentral
6.
go back to reference Masters JR, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P, et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci U S A. 2001;98:8012–7.CrossRefPubMedPubMedCentral Masters JR, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P, et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci U S A. 2001;98:8012–7.CrossRefPubMedPubMedCentral
8.
go back to reference Parson W, Kirchebner R, Muhlmann R, Renner K, Kofler A, Schmidt S, et al. Cancer cell line identification by short tandem repeat profiling: power and limitations. FASEB J. 2005;19:434–6.PubMed Parson W, Kirchebner R, Muhlmann R, Renner K, Kofler A, Schmidt S, et al. Cancer cell line identification by short tandem repeat profiling: power and limitations. FASEB J. 2005;19:434–6.PubMed
9.
go back to reference Nims RW, Sykes G, Cottrill K, Ikonomi P, Elmore E. Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification. In Vitro Cell Dev Biol Anim. 2010;46:811–9.CrossRefPubMedPubMedCentral Nims RW, Sykes G, Cottrill K, Ikonomi P, Elmore E. Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification. In Vitro Cell Dev Biol Anim. 2010;46:811–9.CrossRefPubMedPubMedCentral
10.
go back to reference Cell line misidentification: the beginning of the end. Nat Rev Cancer 2010, 10:441–448. Cell line misidentification: the beginning of the end. Nat Rev Cancer 2010, 10:441–448.
11.
go back to reference Capes-Davis A, Theodosopoulos G, Atkin I, Drexler HG, Kohara A, MacLeod RA, et al. Check your cultures! A list of cross-contaminated or misidentified cell lines. Int J Cancer. 2010;127:1–8.CrossRefPubMed Capes-Davis A, Theodosopoulos G, Atkin I, Drexler HG, Kohara A, MacLeod RA, et al. Check your cultures! A list of cross-contaminated or misidentified cell lines. Int J Cancer. 2010;127:1–8.CrossRefPubMed
12.
go back to reference Gartler SM. Genetic markers as tracers in cell culture. Natl Cancer Inst Monogr. 1967;26:167–95.PubMed Gartler SM. Genetic markers as tracers in cell culture. Natl Cancer Inst Monogr. 1967;26:167–95.PubMed
13.
go back to reference Masters JR, Bedford P, Kearney A, Povey S, Franks LM. Bladder cancer cell line cross-contamination: identification using a locus-specific minisatellite probe. Br J Cancer. 1988;57:284–6.CrossRefPubMedPubMedCentral Masters JR, Bedford P, Kearney A, Povey S, Franks LM. Bladder cancer cell line cross-contamination: identification using a locus-specific minisatellite probe. Br J Cancer. 1988;57:284–6.CrossRefPubMedPubMedCentral
14.
go back to reference Thacker J, Webb MB, Debenham PG. Fingerprinting cell lines: use of human hypervariable DNA probes to characterize mammalian cell cultures. Somat Cell Mol Genet. 1988;14:519–25.CrossRefPubMed Thacker J, Webb MB, Debenham PG. Fingerprinting cell lines: use of human hypervariable DNA probes to characterize mammalian cell cultures. Somat Cell Mol Genet. 1988;14:519–25.CrossRefPubMed
15.
go back to reference King BL, Lichtenstein A, Berenson J, Kacinski BM. A polymerase chain reaction-based microsatellite typing assay used for tumor cell line identification. Am J Pathol. 1994;144:486–91.PubMedPubMedCentral King BL, Lichtenstein A, Berenson J, Kacinski BM. A polymerase chain reaction-based microsatellite typing assay used for tumor cell line identification. Am J Pathol. 1994;144:486–91.PubMedPubMedCentral
16.
go back to reference Reid Y, Storts D, Riss T, Minor L: Authentication of human cell lines by STR DNA profiling analysis. 2004. Reid Y, Storts D, Riss T, Minor L: Authentication of human cell lines by STR DNA profiling analysis. 2004.
17.
go back to reference Boonstra JJ, van Marion R, Beer DG, Lin L, Chaves P, Ribeiro C, et al. Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. J Natl Cancer Inst. 2010;102:271–4.CrossRefPubMedPubMedCentral Boonstra JJ, van Marion R, Beer DG, Lin L, Chaves P, Ribeiro C, et al. Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. J Natl Cancer Inst. 2010;102:271–4.CrossRefPubMedPubMedCentral
18.
go back to reference Langdon SP: Cancer cell culture. Methods and protocols. Humana Press Inc, Totowa, NJ 2004, 88:83–85. Langdon SP: Cancer cell culture. Methods and protocols. Humana Press Inc, Totowa, NJ 2004, 88:83–85.
19.
go back to reference Langdon SP. Basic principles of cancer cell culture. Methods and protocols. Totowa, NJ: Humana Press Inc; 2004. 88:pp 114. Langdon SP. Basic principles of cancer cell culture. Methods and protocols. Totowa, NJ: Humana Press Inc; 2004. 88:pp 114.
20.
go back to reference Hu Y, Lam KY, Wan TS, Fang W, Ma ES, Chan LC, et al. Establishment and characterization of HKESC-1, a new cancer cell line from human esophageal squamous cell carcinoma. Cancer Genet Cytogenet. 2000;118:112–20.CrossRefPubMed Hu Y, Lam KY, Wan TS, Fang W, Ma ES, Chan LC, et al. Establishment and characterization of HKESC-1, a new cancer cell line from human esophageal squamous cell carcinoma. Cancer Genet Cytogenet. 2000;118:112–20.CrossRefPubMed
21.
go back to reference Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer. 1992;69:277–84.CrossRefPubMed Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer. 1992;69:277–84.CrossRefPubMed
22.
go back to reference Cheung LC, Tang JC, Lee PY, Hu L, Guan XY, Tang WK, et al. Establishment and characterization of a new xenograft-derived human esophageal squamous cell carcinoma cell line HKESC-4 of Chinese origin. Cancer Genet Cytogenet. 2007;178:17–25.CrossRefPubMed Cheung LC, Tang JC, Lee PY, Hu L, Guan XY, Tang WK, et al. Establishment and characterization of a new xenograft-derived human esophageal squamous cell carcinoma cell line HKESC-4 of Chinese origin. Cancer Genet Cytogenet. 2007;178:17–25.CrossRefPubMed
23.
go back to reference Hu YC, Lam KY, Law SY, Wan TS, Ma ES, Kwong YL, et al. Establishment, characterization, karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3: two newly established human esophageal squamous cell carcinoma cell lines. Cancer Genet Cytogenet. 2002;135:120–7.CrossRefPubMed Hu YC, Lam KY, Law SY, Wan TS, Ma ES, Kwong YL, et al. Establishment, characterization, karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3: two newly established human esophageal squamous cell carcinoma cell lines. Cancer Genet Cytogenet. 2002;135:120–7.CrossRefPubMed
24.
go back to reference Drexler HG, Dirks WG, Matsuo Y, MacLeod RA. False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia. 2003;17:416–26.CrossRefPubMed Drexler HG, Dirks WG, Matsuo Y, MacLeod RA. False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia. 2003;17:416–26.CrossRefPubMed
25.
go back to reference Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, et al. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab. 2008;93:4331–41.CrossRefPubMedPubMedCentral Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, et al. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab. 2008;93:4331–41.CrossRefPubMedPubMedCentral
26.
go back to reference van Helden PD, Wiid IJ, Albrecht CF, Theron E, Thornley AL, Hoal-van Helden EG. Cross-contamination of human esophageal squamous carcinoma cell lines detected by DNA fingerprint analysis. Cancer Res. 1988;48:5660–2.PubMed van Helden PD, Wiid IJ, Albrecht CF, Theron E, Thornley AL, Hoal-van Helden EG. Cross-contamination of human esophageal squamous carcinoma cell lines detected by DNA fingerprint analysis. Cancer Res. 1988;48:5660–2.PubMed
27.
go back to reference Budowle B, Moretti TR, Niezgoda SJ, Brown BL: CODIS and PCR-based short tandem repeat loci: law enforcement tools. Second European Symposium on Human Identification 1998:73–88. Budowle B, Moretti TR, Niezgoda SJ, Brown BL: CODIS and PCR-based short tandem repeat loci: law enforcement tools. Second European Symposium on Human Identification 1998:73–88.
28.
go back to reference Vauhkonen H, Hedman M, Vauhkonen M, Kataja M, Sipponen P, Sajantila A. Evaluation of gastrointestinal cancer tissues as a source of genetic information for forensic investigations by using STRs. Forensic Sci Int. 2004;139:159–67.CrossRefPubMed Vauhkonen H, Hedman M, Vauhkonen M, Kataja M, Sipponen P, Sajantila A. Evaluation of gastrointestinal cancer tissues as a source of genetic information for forensic investigations by using STRs. Forensic Sci Int. 2004;139:159–67.CrossRefPubMed
30.
go back to reference Lorenzi PL, Reinhold WC, Varma S, Hutchinson AA, Pommier Y, Chanock SJ, et al. DNA fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther. 2009;8:713–24.CrossRefPubMedPubMedCentral Lorenzi PL, Reinhold WC, Varma S, Hutchinson AA, Pommier Y, Chanock SJ, et al. DNA fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther. 2009;8:713–24.CrossRefPubMedPubMedCentral
Metadata
Title
Authentication of newly established human esophageal squamous cell carcinoma cell line (YM-1) using short tandem repeat (STR) profiling method
Authors
Khosravi Ayyoob
Khoshnia Masoud
Kazeminejad Vahideh
Asadi Jahanbakhsh
Publication date
01-03-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 3/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4133-4

Other articles of this Issue 3/2016

Tumor Biology 3/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine